CHAAN S NG to Pancreatic Neoplasms
This is a "connection" page, showing publications CHAAN S NG has written about Pancreatic Neoplasms.
Connection Strength
0.307
-
Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am. 2007 Jun; 21(3):409-32; vii.
Score: 0.084
-
Comparison of virtual to true unenhanced abdominal computed tomography images acquired using rapid kV-switching dual energy imaging. PLoS One. 2020; 15(9):e0238582.
Score: 0.053
-
A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors. Pancreas. 2019 03; 48(3):381-386.
Score: 0.047
-
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. Lancet Oncol. 2015 Jun; 16(6):695-703.
Score: 0.036
-
Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience. Cancer. 2011 Jan 01; 117(1):77-85.
Score: 0.026
-
Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008 Jul 15; 14(14):4491-9.
Score: 0.023
-
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol. 2006 Mar 01; 24(7):1145-51.
Score: 0.019
-
Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging. 2005 Jul-Aug; 29(4):263-5.
Score: 0.018